You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEGylated Recombinant Human Hyaluronidase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in United States (Eribulin mesylate, Biologic: PEGylated recombinant human hyaluronidase

Terminated
Has Results
  • Metastatic Breast Cancer
  • Eribulin mesylate
  • +2 more
  • Whittier, California
  • +6 more
Jun 25, 2020

HIV Trial in Las Vegas (Cabotegravir 200 mg/mL, Cabotegravir 400 mg/mL, Recombinant human hyaluronidase PH20 (rHuPH20))

Recruiting
  • HIV Infections
  • Cabotegravir 200 mg/mL
  • +2 more
  • Orlando, Florida
  • +3 more
Dec 1, 2022

PEGylated GH for Treatment of Short Stature in Chinese

Recruiting
  • Growth Hormone Treatment
  • Growth Disorders
  • Polyethylene glycol recombinant human growth hormone injection
  • Beijing, Beijing, China
    Department of Endocrinology, Genetics, Metabolism
Sep 12, 2023

Healthy Trial in London (Ravulizumab, rHuPH20)

Completed
  • Healthy
  • London, United Kingdom
    Clinical Trial Site
May 25, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Houston (Pegylated Recombinant Human

Withdrawn
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Pegylated Recombinant Human Hyaluronidase PH20
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Mar 11, 2020

HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)

Completed
  • HIV Antibodies
  • VRC-HIVMAB091-00-AB
  • EDP
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 8, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • HYQVIA
  • (no location specified)
Feb 23, 2023

Outcomes Study (FIGARO)

Completed
  • Primary Immunodeficiency
  • Secondary Immune Deficiency
  • HyQvia
  • Paris, France
  • +3 more
Mar 18, 2022

Metastatic Pancreatic Adenocarcinoma Trial in United States (PEGPH20, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Anchorage, Alaska
  • +153 more
Nov 29, 2021

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

NSCLC, Gastric Cancer Trial in United States (PEGPH20, Pembrolizumab)

Completed
Has Results
  • NSCLC
  • Gastric Cancer
  • Birmingham, Alabama
  • +27 more
Jan 24, 2020

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • (no location specified)
Jun 13, 2022

Plasma Cell Myeloma Trial in Philadelphia (Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life

Not yet recruiting
  • Plasma Cell Myeloma
  • Daratumumab and Hyaluronidase-fihj
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 19, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil

Recruiting
  • Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
  • 5-Fluorouracil (5-FU)
  • +11 more
  • Scottsdale, Arizona
  • +41 more
Jan 19, 2023

Cancer, Pediatric Solid Tumor, Pediatric AML Trial in Australia, United Kingdom (PEG- BCT-100)

Completed
  • Cancer
  • +3 more
  • PEG- BCT-100
  • Adelaide, Australia
  • +13 more
Sep 1, 2022

Primary Immunodeficiency Diseases (PID) Trial in Centennial, North Palm Beach, Dallas (Recombinant human hyaluronidase + immune

Completed
  • Primary Immunodeficiency Diseases (PID)
  • Recombinant human hyaluronidase + immune globulin intravenous
  • Centennial, Colorado
  • +2 more
Apr 30, 2021

Hereditary Angioedema Trial in United States (CINRYZE with rHuPH20)

Completed
Has Results
  • Hereditary Angioedema
  • CINRYZE with rHuPH20
  • Scottsdale, Arizona
  • +3 more
Jun 16, 2021

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +10 more
  • Atezolizumab and Recombinant Human Hyaluronidase
  • Survey Administration
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Healthy Volunteers Trial in Hialeah (TAK-881)

Completed
  • Healthy Volunteers
  • TAK-881
  • Hialeah, Florida
    Clinical Pharmacology of Miami
Apr 28, 2022

Bladder Cancer Trial in United States (Mitomycin C, Chemophase)

Completed
Has Results
  • Bladder Cancer
  • Phoenix, Arizona
  • +4 more
Sep 30, 2021

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Sep 23, 2023